López Medrano, Francisco
Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). [guía clínica] - Enfermedades infecciosas y microbiología clínica, 2015 - 33(10):679.e1-679.e21.
Formato Vancouver:
Vidal E, Cervera C, Cordero E, Armiñanzas C, Carratalá J, Cisneros JM et al; Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC); Spanish Network for Research in Infectious Diseases (REIPI). Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enferm Infecc Microbiol Clin. 2015 Dec;33(10):679.e1-679.e21.
PMID: 25976754
Contiene 218 referencias
Background: Urinary tract infections (UTIs) are one of the most common infections in solid organ transplant (SOT) recipients.
Methods: Experienced SOT researchers and clinicians have developed and implemented this consensus document in support of the optimal management of these patients. A systematic review was conducted, and evidence levels based on the available literature are given for each recommendation. This article was written in accordance with international recommendations on consensus statements and the recommendations of the Appraisal of Guidelines for Research and Evaluation II (AGREE II).
Results: Recommendations are provided on the management of asymptomatic bacteriuria, and prophylaxis and treatment of UTI in SOT recipients. The diagnostic-therapeutic management of recurrent UTI and the role of infection in kidney graft rejection or dysfunction are reviewed. Finally, recommendations on antimicrobials and immunosuppressant interactions are also included.
Conclusions: The latest scientific information on UTI in SOT is incorporated in this consensus document.
Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). [guía clínica] - Enfermedades infecciosas y microbiología clínica, 2015 - 33(10):679.e1-679.e21.
Formato Vancouver:
Vidal E, Cervera C, Cordero E, Armiñanzas C, Carratalá J, Cisneros JM et al; Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC); Spanish Network for Research in Infectious Diseases (REIPI). Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enferm Infecc Microbiol Clin. 2015 Dec;33(10):679.e1-679.e21.
PMID: 25976754
Contiene 218 referencias
Background: Urinary tract infections (UTIs) are one of the most common infections in solid organ transplant (SOT) recipients.
Methods: Experienced SOT researchers and clinicians have developed and implemented this consensus document in support of the optimal management of these patients. A systematic review was conducted, and evidence levels based on the available literature are given for each recommendation. This article was written in accordance with international recommendations on consensus statements and the recommendations of the Appraisal of Guidelines for Research and Evaluation II (AGREE II).
Results: Recommendations are provided on the management of asymptomatic bacteriuria, and prophylaxis and treatment of UTI in SOT recipients. The diagnostic-therapeutic management of recurrent UTI and the role of infection in kidney graft rejection or dysfunction are reviewed. Finally, recommendations on antimicrobials and immunosuppressant interactions are also included.
Conclusions: The latest scientific information on UTI in SOT is incorporated in this consensus document.
